1
Recursion Pharmaceuticals’ AI drug discovery will boost following investment from Nvidia.
2
The new funds ensure Recursion as the leading AI-driven biotech firm, as per Gil Blum, an analyst at Needham & Co.
Chip manufacturing giant Nvidia (NASDAQ: NVDA) invested $50 Million in Recursion Pharmaceuticals Inc. (NASDAQ: RXRX). Following the funding, the chip-making company’s NVDA stock rose to over 8% since the announcement, and Recursion’s RXRX stock price surged up to 80% during the same timeframe.
Recursion Pharmaceuticals is a known company indulged in the development of artificial intelligence (AI) based models for drug discovery. The company has biological …
We współpracy z: https://www.thecoinrepublic.com/2023/07/14/recursion-pharmaceuticals-receives-50m-rxrx-stock-shoots-80/
